Will Phase II - Rapamycin/Acarbose significantly extend the lifespan of UM-HET3mice tested by the NIA’s Interventions Testing Program? (Cohort 13: C2017)

10

121Ṁ412

resolved Jan 1

Resolved

YES

1H

6H

1D

1W

1M

ALL

...treatments that can decelerate the rate of aging are the only available path to significantly increase human lifespan going forward. Before drugs and treatments can be considered for larger clinical studies in humans, pilot trials in rodents must be performed as a necessary prerequisite. This is why the National Institute on Aging established the Interventions Testing Program which “is a multi-institutional study investigating treatments with the potential to extend lifespan and delay disease and dysfunction in mice”. So far it is the largest systematic effort to test potentially life-extending compounds in mice that has been performed. This is an attempt to give the biogerontology community, interested experts and laypeople an opportunity to predict outcomes of this important experiment. See also: http://biogerontolgy.blogspot.com/2022/02/a-prediction-market-for-nias-mouse.html

Get

1,000

to start trading!

🏅 Top traders

#	Name	Total profit
1		Ṁ43
2		Ṁ8
3		Ṁ8
4		Ṁ0

People are also trading

Will Captopril significantly extend the lifespan of UM-HET3 mice tested by the NIA’s Interventions Testing Program? (Cohort 13: C2017)

Will 1,3-butanediol significantly extend the lifespan of UM-HET3 mice tested by the NIA’s Interventions Testing Program? (Cohort 13: C2017)

Will a study performed by the Dog Aging Project show a statistically significant effect of rapamycin on lifespan extension between control groups and a treatment group?

Will Aubrey de Grey's 2022 Robust Mouse Rejuvenation Project "succeed" in its aims of finding an intervention that increases both mean and maximum lifespan of mice by at least 12 months?

Will the Rapamycin - Effects on Alzheimer's and Cognitive Health (REACH) trial show that Rapamycin improves Alzheimer's

Does rapamyacin significantly increase the lifespan of dogs?

What will be the next compound tested by the Interventions Testing Program (ITP) shown to have a statistically significant effect on lifespan?

Will a study show that the combination of parabiosis + genetic reprogramming will improve lifespan more than either intervention alone by 2035?

What will be the next compound produced and tested by the ITP that will be shown to have a statistically significant effect on both median and 90th percentile lifespan?

What percent of those taking rapamycin to slow aging will comment a positive or neutral review?

Related questions

Will Captopril significantly extend the lifespan of UM-HET3 mice tested by the NIA’s Interventions Testing Program? (Cohort 13: C2017)

Will 1,3-butanediol significantly extend the lifespan of UM-HET3 mice tested by the NIA’s Interventions Testing Program? (Cohort 13: C2017)

Will a study performed by the Dog Aging Project show a statistically significant effect of rapamycin on lifespan extension between control groups and a treatment group?

Will Aubrey de Grey's 2022 Robust Mouse Rejuvenation Project "succeed" in its aims of finding an intervention that increases both mean and maximum lifespan of mice by at least 12 months?

Will the Rapamycin - Effects on Alzheimer's and Cognitive Health (REACH) trial show that Rapamycin improves Alzheimer's

Does rapamyacin significantly increase the lifespan of dogs?

What will be the next compound tested by the Interventions Testing Program (ITP) shown to have a statistically significant effect on lifespan?

Will a study show that the combination of parabiosis + genetic reprogramming will improve lifespan more than either intervention alone by 2035?

What will be the next compound produced and tested by the ITP that will be shown to have a statistically significant effect on both median and 90th percentile lifespan?

What percent of those taking rapamycin to slow aging will comment a positive or neutral review?

© Manifold Markets, Inc.•Terms•Privacy